ICU fungus study aims to uncover resistance secrets
NCT ID NCT07245563
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will look at Candida fungi from 300 patients in a hematology ICU. Researchers want to see how often these fungi form biofilms (slimy layers that protect them) and whether that makes them resistant to antifungal drugs. The goal is to learn which Candida types are most common and what factors lead to harder-to-treat infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose better antifungal treatments for ICU patients with Candida infections.
- What could go wrong
- This is an observational study, not testing a new treatment. It may not directly change patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDA INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a quick PCR test speed up lifesaving fungal infection diagnosis?
- Baby thrush may predict cavity risk: study investigates link
- Blood biomarkers may let ICU patients stop antifungals earlier
- Could 7 days of antifungals be enough for kids with blood infections?
- Candida resistance study pulled before it began
- New blood tests could speed up detection of deadly fungal infections